Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-20-021855
Filing Date
2020-08-13
Accepted
2020-08-13 16:02:19
Documents
1
Period of Report
2020-08-11

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3962
  Complete submission text file 0001213900-20-021855.txt   5338
Mailing Address
Business Address
SIECZKAREK MARK M (Reporting) CIK: 0001188738 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52545 | Film No.: 201099230

Mailing Address 24 HANAGAR ST HOD HASHARON L3 4527713
Business Address 24 HANAGAR ST HOD HASHARON L3 4527713 972 472 260 0536
Wize Pharma, Inc. (Issuer) CIK: 0001218683 (see all company filings)

EIN.: 880445167 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations